Concepedia

Vladimir Chulanov

VC

Statistics

Publications

47

Citations

3K

H-Index

24

Active since

2003

Affiliations

Sechenov University(Current)

Central Research Institute of Epidemiology

Medizinische Hochschule Hannover

Sirius University of Science and Technology

Federal Medical-Biological Agency

Vladimir Chulanov is an author at Sechenov University specializing in viral hepatitis, infectious diseases, and viral hepatitis treatment.

ORCID

Publications per year

2003–2025

47

Publications

47

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

Péter Ferenci, David Bernstein, Jacob Lalezari et al. · New England Journal of Medicine · 2014 · 695 citations · Full text

, , +16

Hepatitis B Virus Genotypes in Alaska Native People with Hepatocellular Carcinoma: Preponderance of Genotype F

Stephen Livingston, Josephine Simonetti, Brian J. McMahon et al. · The Journal of Infectious Diseases · 2006 · 245 citations · Full text

, , +16

A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D

Heiner Wedemeyer, Soo Aleman, Maurizia Rossana Brunetto et al. · New England Journal of Medicine · 2023 · 215 citations · Full text

, , +13

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial

Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov et al. · The Lancet Infectious Diseases · 2022 · 158 citations

, , +13

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1–6 and compensated cirrhosis: The EXPEDITION-8 trial

Robert S. Brown, Lino Rodrigues, Vladimir Chulanov et al. · Journal of Hepatology · 2019 · 155 citations

, , +17

1–5 of 47